Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 13,362 | 15,741 | 14,350 | 0 |
| Operating Income | -13,362 | -15,741 | -14,350 | N/A |
| Other Income | 107 | 219 | 327 | 0 |
| Pre-tax Income | -13,255 | -15,522 | -14,023 | 0 |
| Net Income Continuous | -13,255 | -15,522 | -14,023 | N/A |
| Net Income | $-13,255 | $-15,522 | $-14,023 | $N/A |
| EPS Basic Total Ops | -8.53 | -10.82 | -10.90 | N/A |
| EPS Basic Continuous Ops | -7.73 | -9.95 | -9.95 | N/A |
| EPS Diluted Total Ops | -8.53 | -10.82 | -10.90 | N/A |
| EPS Diluted Continuous Ops | -7.73 | -9.95 | -9.95 | N/A |
| EBITDA(a) | $-13,075 | $-15,461 | $-14,094 | $N/A |